Evidence review: Gender-affirming hormones for children and adolescents with gender dysphoria

Source:
National Institute for Health and Care Excellence - NICE
Publisher:
National Institute for Health and Care Excellence (NICE);NHS England;NHS Improvement
Publication date:
11 March 2021

Abstract

This document will help inform Dr Hilary Cass’ independent review into gender identity services for children and young people. It was commissioned by NHS England and Improvement who commissioned the Cass review. It aims to assess the evidence for the clinical effectiveness, safety and cost-effectiveness of gender-affirming hormones for children and adolescents aged 18 years or under with gender dysphoria. The document was prepared by NICE in October 2020.